Dolutegravir dispersible tablet

DRUG2 trials

Sponsors

ViiV Healthcare

Conditions

HIV InfectionsInfection, Human Immunodeficiency Virus

Phase 1

Bioavailability Study of a Dolutegravir Dispersible Tablet and Effect of Different Types of Water on the Dispersible Tablet in Healthy Volunteers

CompletedNCT02185300

ViiV HealthcareInfection, Human Immunodeficiency Virus

Start: 2014-07-31End: 2014-09-30Updated: 2014-12-02

Dolutegravir Pediatric Liquid Formulation Study

CompletedNCT03921723

ViiV HealthcareHIV Infections

Start: 2019-05-07End: 2019-07-25Updated: 2020-07-31